Overview
Crystagen is a short regulatory peptide studied in immune-cell, thymic, and gene-expression pathway research models. It is supplied as lyophilized powder in a 20 mg presentation for laboratory research workflows only.

Crystagen is a short regulatory peptide studied in immune-cell, thymic, and gene-expression pathway research models. It is supplied as lyophilized powder in a 20 mg presentation for laboratory research workflows only.
Crystagen is a short regulatory peptide studied in immune-cell, thymic, and gene-expression pathway research models. It is supplied as lyophilized powder in a 20 mg presentation for laboratory research workflows only.
Batch CRY014-150626 is linked to product specifications and analytical documentation.
Open certificate library →| Molecular Formula | To be confirmed by batch COA |
|---|---|
| Molecular Weight | To be confirmed by batch COA |
| Sequence | To be confirmed by batch COA |
| Product Form | Lyophilized Powder |
| Presentation | 20 mg / 10 Vials |
| Batch Number | CRY014-150626 |
| Testing | HPLC purity verification; third-party COA recommended for final release |
| Appearance | White to off-white lyophilized powder |
| Storage | Store according to batch COA and internal laboratory SOP. Protect from light and avoid repeated freeze-thaw cycles where applicable. |
| Research Use | For laboratory Research Use Only (RUO). |